Late ‐onset hypogonadism: Prostate safety
ConclusionTestosterone replacement therapy could be considered for most men with late ‐onset hypogonadism regardless of their history of prostate disease. However, a discussion about the risks and benefits of testosterone replacement therapy is always advised, especially in men with prostate cancer. Appropriate monitoring is mandatory.
Source: Andrology - Category: Urology & Nephrology Authors: Eduardo P. Miranda,
Luiz Ot ávio Torres Tags: REVIEW ARTICLE Source Type: research
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Low Testosterone | Metabolic Syndrome | Prostate Cancer | Study | Urology & Nephrology